2023
DOI: 10.31612/2616-4868.1(23).2023.04
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Early Treatment- Emergent Complications of Stage Iii a Non-Small Cell Carcinoma (Nsclc Stage Iii A) in Patients Treated With Neoadjuvant Chemoradiotherapy (Nhlt), (Ncht), and Neoadjuvant Chemotherapy and Adjuvant Radiation Therapy

K. A. Malyarchuk,
A. V. Ganul,
B. O. Borysyuk
et al.

Abstract: Treatment of STAGE III A NSCLC is an extremely difficult problem for modern oncology, since the one-year survival rate from the moment of diagnosis according to the National Cancer Registry is up to 58%. At the same time, there is a situation of uncertainty in the clinical approach to the treatment of this pathology – neither NCCN nor other world scientific literature sources contain information regarding a specific treatment method. The advantage of none of the possible methods of treatment of stage III NSCLC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 6 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?